| Literature DB >> 35840923 |
Riris Andono Ahmad1,2, Luca Nelli3,4, Gillian Stresman5, Lindsey Wu5, Henry Surendra1,6, Risalia Reni Arisanti1,2, Dyah Ayu Shinta Lesmanawati1, Isabel Byrne5, Elin Dumont5, Chris Drakeley5.
Abstract
BACKGROUND: The effectiveness of a surveillance system to detect infections in the population is paramount when confirming elimination. Estimating the sensitivity of a surveillance system requires identifying key steps in the care-seeking cascade, from initial infection to confirmed diagnosis, and quantifying the probability of appropriate action at each stage. Using malaria as an example, a framework was developed to estimate the sensitivity of key components of the malaria surveillance cascade.Entities:
Keywords: Care seeking; Decision-making; Freedom from infection; Global health; Malaria elimination; Public health; Surveillance sensitivity
Mesh:
Substances:
Year: 2022 PMID: 35840923 PMCID: PMC9288013 DOI: 10.1186/s12879-022-07581-2
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.667
Fig. 1Magelang and Kulon Progo Districts in Indonesia, and location of health facilities. Background images source: OpenStreetMap
Survey questions at health facilities in Kulon Progo and Magelang Districts
| | What is the estimated catchment population size of your health facility? |
| | What is the estimated average monthly number of outpatient attendees for your health facility? |
| | What percentage of patients reporting at your facility are from outside your catchment area? |
| | What district are they normally a resident of? |
| | What percentage of your total facility attendance reported fever in the last week? |
| | What percentage of attendees were diagnosed for uncomplicated malaria in the last year? |
| | What percentage of attendees were diagnosed for severe malaria in the last year? |
| | Does your facility provide malaria microscopy testing? |
| | Do you have functioning electronic microscopes with dual eyepieces available? |
| | Do you have functioning microscopy counting meters available? |
| | Has your facility experienced stock-outs of material to conduct microscopy in the last year? |
| | Which month was the stock-out? |
| | What was the length of the stock-out? |
| | Does your facility provide malaria testing by RDT? |
| | Has your facility experienced RDT stock-outs of material in the last year? |
| | Which month was the stock-out? |
| | What was the length of the stock-out? |
| | Does your facility provide antimalarials? (first-line ACT, injectable artesunate for severe malaria, or other) |
| | Has your facility experienced stock-outs of antimalarials in the last year? |
| | Which month was the stock-out? |
| | What was the length of the stock-out? |
| | Do you confirm suspected samples with testing at reference laboratories? |
| | Which samples do you send to confirm at reference laboratories? |
| | Specify criteria for sending samples to reference laboratory: |
| | Which reference laboratory do you send your samples to for confirmation? |
| | Do you have staff available at your facility to conduct malaria microscopy? |
| | Have your staff received training on malaria diagnosis by microcopy? |
| | When was the last microscopy training received? |
| | Was a competency certificate received? |
| | Do you have staff available at your facility to conduct RDTs? |
| | Have your staff received training on malaria diagnosis by RDT? |
| | When was the last training received? |
| | Have community health workers that report to your facility received training on malaria diagnosis by RDT? |
| | When was the last training received? |
| | Have your staff ever received training or attended workshops on malaria case management? |
| | When was the last training received/workshop attended? |
| | Is a copy of the national malaria treatment guidelines or standard operating procedures on malaria case management available in your facility? |
| | Has your facility received supervisory visits from a district health officer or consultant in the last year? |
| | When was the last visit? |
| | Can you show me the facility records for number of patients suspected for malaria in the last 2–3 years? |
| | What are the reasons for not keeping records on patients suspected? |
| | Can you show me the facility records for number of patients tested for malaria in the last 2–3 years? |
| | What are the reasons for not keeping records on patients tested? |
| | Can you show me the facility records for number of confirmed malaria cases in the last 2–3 years? |
| | What are the reasons for not keeping records on confirmed cases? |
| | Can you show me the facility records for number of confirmed |
| | What are the reasons for not keeping records on confirmed |
| | Can you show me the online record of your facility’s submissions on the number of patients suspected, tested and confirmed for malaria to the national database in the last 2–3 years? |
| | What is your case definition/criteria to test a patient for malaria? |
| | What is the case definition for a |
| | Is this facility able to conduct epidemiological investigations to confirm |
| | What is the case definition for an imported case for this facility? |
| | Describe the epidemiological investigation process your district uses to confirm if a case is imported or indegenous |
Fig. 2Schematic representation of the surveillance data flow for estimating the sensitivity of a surveillance system, for the ith month and jth health facility. : patients attending the health facility, : patients reporting fever, : patients being suspected for malaria, : patients being tested for malaria, : patients being confirmed with malaria, : probability of care seeking, : probability of having clinical symptoms (fever), : probability of being suspected for malaria, : probability of being tested for malaria, : probability of being confirmed with malaria
Summary of health facility responses in Kulon Progo and Magelang Districts
| Question | Answer (%) | ||
|---|---|---|---|
| Antimalarial materials | Yes | No | |
| 32.3 | 67.7 | ||
| Yes | No | ||
| 25.0 | 55.0 | ||
| 3.6/1–8 | |||
| Microscopy materials | Yes | No | |
| 82.3 | 17.7 | ||
| Yes | No | ||
| 98.0 | 2.0 | ||
| 48.0 | 52.0 | ||
| 13.7 | 86.3 | ||
| 3.6/1–12 | |||
| RDT materials | Yes | No | |
| 14.5 | 85.5 | ||
| Yes | No | ||
| 44.4 | 55.6 | ||
| 4.0/1–6 | |||
| Reference laboratories | Yes | No | |
| 64.5 | 35.5 | ||
| Yes | No | ||
| 53.8 | 46.2 | ||
| Microscopy training | Yes | No | |
| 79.0 | 21.0 | ||
| Yes | No | ||
| 89.8 | 10.2 | ||
| 56.8 | 43.2 | ||
| 2.9/0.9–16.9 | |||
| RDT training | Yes | No | |
| 35.5 | 64.5 | ||
| Yes | No | 52.4 | |
| 47.6 | 52.4 | ||
| 3.9/1.8–7.9 | |||
| Yes | No | ||
| 30.6 | 69.4 | ||
| 1.5/0.9–2.0 | |||
| Case training | Yes | No | |
| 50.0 | 50.0 | ||
| 3.5/0.9–17.0 | |||
| 61.3 | 38.7 | ||
| 30.6 | 69.4 | ||
| 1.2/0.9–4.9 | |||
| Case reporting | Yes | No | |
| 56.5 | 43.5 | ||
| 56.5 | 43.5 | ||
| 51.6 | 48.4 | ||
| 51.6 | 48.4 | ||
| 32.3 | 67.7 | ||
Responses to each survey question are summarised by proportion of total facilities interviewed (or average and range, in case of numerical values). Not shown in the summary table are descriptions of each facility’s malaria case definition, case and relapse definition for P. vivax, and P. vivax case investigation procedure
Result of Bayesian models of probability of care seeking () and probability of being tested for malaria (), as a function of antimalarial availability at health facilities in Kulon Progo and Magelang Districts
| Model | Variable | 95% LCI | 95% UCI | |
|---|---|---|---|---|
| − 3.501 | − 3.589 | − 2.640 | ||
| 1.093 | 0.430 | 1.151 | ||
| − 1.164 | − 1.195 | − 0.921 | ||
| − 0.044 | − 0.075 | − 0.041 | ||
| − 6.100 | − 6.941 | − 5.454 | ||
| 1.992 | 1.290 | 3.026 | ||
| 0.549 | 0.532 | 0.566 | ||
| 3.095 | 2.717 | 3.482 | ||
| − 1.098 | − 1.145 | − 1.001 | ||
| 0.052 | − 0.450 | 0.314 | ||
| 0.015 | 0.009 | 0.032 | ||
| − 0.625 | − 4.659 | 4.593 | ||
| 0.060 | 0.037 | 0.085 | ||
| 0.110 | 0.088 | 0.131 |
β: mean of posterior distribution, LCI: lower credible interval, UCI: upper credible interval
Fig. 3Expected probability of care seeking (PSEEK) and probability of being tested for malaria (PTEST), obtained from the mean of the posterior distribution of the Bayesian model fit, together with their standard deviation (error bars)
Fig. 4Months since last reported malaria case, expected probability of care seeking (PSEEK) and probability of being tested for malaria (PTEST), obtained from the mean of the posterior distribution of the Bayesian models, in Magelang and Kulon Progo districts (Indonesia)
Fig. 5Relationship between A probability of care seeking (PSEEK) and probability of being tested for malaria (PTEST), B and time since last reported malaria case, C and time since the last reported malaria case, obtained from the mean of the posterior distribution of the Bayesian models, in Magelang and Kulon Progo districts (Indonesia)